CLOBEX generic manufacturers

Galderma is a leading global dermatology company that provides a diverse range of medical and consumer skin health solutions. The company is the innovator and brand owner of Clobex (clobetasol propionate), a high-potency topical corticosteroid used to treat inflammatory skin conditions such as psoriasis and dermatitis. Galderma's business is organized into three main categories: Injectable Aesthetics, Therapeutic Dermatology, and Daily Skincare, featuring flagship brands like Cetaphil, Restylane, and Dysport. While Galderma maintains the branded Clobex market, the product is widely available as a generic from manufacturers such as Teva, Padagis, and Glenmark. The company recently transitioned to a public entity following a successful IPO on the SIX Swiss Exchange in 2024.